Patent · US Active

Diagnostic agent and therapeutic agent for pancreatic cancer

US8273859B2 · kind B2 · utility

0Cited by
0References
29Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 14, 2011
Grant dateSep 25, 2012
Priority date
Expiry dateJul 14, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a novel diagnostic or therapeutic method for pancreatic cancer employing a blood marker. The present invention provides a diagnostic or therapeutic drug for pancreatic cancer containing an anti-AMIGO2 antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.